Search

Author/Creator Ferreiro, R

2. Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study. (13th July 2018)

Authors:
Van Cutsem, E; Yoshino, T; Lenz, H J; Lonardi, S; Falcone, A; Limón, M L; Saunders, M; Sobrero, A; Park, Y S; Ferreiro, R; Hong, Y S; Tomasek, J; Taniguchi, H; Ciardiello, F; Stoehr, J; Oum'Hamed, Z; Vlassak, S; Studeny, M; Argiles, G
Journal:
Annals of oncology
Issue:
Volume 29:Number 9(2018)
Page Start:
1955
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P225 Usefulness of monocytosis as biomarker to predict relapse in inflammatory bowel disease patients in remission under maintenance treatment with anti-TNF drugs: A prospective longitudinal cohort study. (16th January 2018)

Authors:
Ferreiro, R; Lopez-Diaz, J; Baston, I; Dominguez-Munoz, J E; Barreiro-de Acosta, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P293 Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients. (16th January 2018)

Authors:
Gonzalez-Lopez, J; Llamas, C; Giráldez-Montero, J M; Ferreiro, R; Baston, I; Lamas, M J; Dominguez-Munoz, J E; Barreiro-de Acosta, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P355 Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study. (27th May 2021)

Authors:
Taxonera Samso, C; Martínez-Montiel, P; Barreiro-De-Acosta, M; Vera, I; Lorente, R; Vega, P; Diz-Lois, M T; Fuentes Coronel, A M; Pérez Calle, J L; Casis, B; Ferreiro, R; Calvo, M; Olivares, D; Alba, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S374
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P505 Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry. (25th January 2019)

Authors:
Iborra, M; Beltrán, B; Fernández, A; Gutiérrez, A; Antolín, B; Huguet, J M; de Francisco, R; Merino, O; Carpio, D; García López, S; Mesonero, F; Mínguez, M; Ferreiro, R; Carbajo, A Y; Rivero, M; Chaparro, M; Piñero-Pérez, M C; Monfort i Miquel, D; Bujanda, L; García-Sepulcre, M F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗